New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Columbia neuroscientists have identified brain-cell circuitry in fruit flies that converts waves of light entering the eye into color perceptions in the brain.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Wei Min, PhD, has found a way to monitor how living cells make proteins, which may open doors to answering enduring questions in neuroscience about the molecular nature of memory.
Deficiency of a protein in the hippocampus is a major cause of age-related memory loss, and this form of memory loss is reversible, according to Columbia researchers.
CUMC's Dr. Eric Kandel (2000 Nobel Laureate) said the project may lead to an understanding of "who we are as human beings and how we function and how these terrible diseases arise, and what we might be able to do address them more effectively."